@misc {TN_libero_mab2,
author = { Spigel, David R. AND Edelman, Martin J. AND Mok, Tony AND O'Byrne, Kenneth John AND Paz-Ares, Luis AND Yu, Wei AND Rittweger, Karen AND Thurm, Holger C. },
title = { The MetLUNG study: A randomized, double-blind, phase III study of onartuzumab (MetMAb) plus erlotinib versus placebo plus erlotinib in patients with advanced, MET-positive non-small cell lung cancer (NSCLC). },
publisher = {American Society of Clinical Oncology (ASCO)},
isbn = {0732-183X},
isbn = {1527-7755},
keywords = { Cancer Research , Oncology },
year = {2012},
url = { http://slubdd.de/katalog?TN_libero_mab2 }
}
Download citation